Sign in

NCT05010603Recruiting

Late Onset Alzheimer's Disease

Source: ClinicalTrials.gov · Last updated 18 May 2026

Brief summary (registry, in English)

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

Status (registry)
Recruiting
Study type
Observational
Enrollment
10000 (estimated)
First submitted
11 Aug 2021
Start date
15 Nov 2016
Primary completion date
30 Apr 2027
Lead sponsor
Columbia University
NCT number
NCT05010603

What you commit to

  • Study type: Observational
  • Planned participants: 10000
  • From 15 Nov 2016 to the primary completion date, 30 Apr 2027
  • 12 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • failure to identify an appropriate informant;
  • uncertainty of the clinical diagnosis of Alzheimer's disease or other related disorder;
  • failure to identify a living sibling with AD or other related disorder (except in the cases of sporadic FTD and sporadic LBD);

Other

  • discovery of additional diagnosis that could account for the clinical manifestations;
  • unwillingness to participate;
  • participants lacking the capacity to consent who do not have a surrogate or proxy or next of kin to provide consent.

Who the study is looking for

  • Established diagnosis of definite or probable AD or have a diagnosis of a related neurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy Body Dementia (LBD) (will also recruit sporadic FTD and LBD) cases.
  • a living sibling with probable or possible AD;
  • a third living relative affected with AD (onset age 50 or older) or unaffected (60 or older);
  • participants in the proband's generation with an identified companion serving as an informant;
  • participants who have capacity to consent or participants lacking capacity to consent with a surrogate/proxy in place to provide consent.

Age in the registry: 55 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Rush University
Coordinator of this site? Confirm its status
AuroraUnited StatesRecruiting
Indiana University
Coordinator of this site? Confirm its status
BloomingtonUnited StatesRecruiting
University of Texas, Southwestern
Coordinator of this site? Confirm its status
DallasUnited StatesRecruiting
NCRAD at Indiana University
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting
University of Miami
Coordinator of this site? Confirm its status
MiamiUnited StatesRecruiting
Columbia University Irving Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
University of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesRecruiting
North Carolina State University
Coordinator of this site? Confirm its status
RaleighUnited StatesRecruiting
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting
University of Washington
Coordinator of this site? Confirm its status
SeattleUnited StatesRecruiting
Joanne Norton
Coordinator of this site? Confirm its status
St LouisUnited StatesRecruiting
University of Washington
Coordinator of this site? Confirm its status
Washington D.C.United StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.